Ryu, M., Lemech, C. R., Ganju, V., Bulat, I., Lee, C., Park, J. O., Khattak, A., Roohullah, A., Kang, B., Zhao, Z., Kalman, T., Wang, S., Yang, Q., Chao, B. H., Nagrial, A. (2026). A global phase 1/2a trial of SHR-A1904, a CLDN18.2-targeting ADC, in advanced solid tumors expressing CLDN18.2.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15018